StockData

VitaNova Life Sciences Corp (VNOV) stock

VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026Market cap $37.52MP/E –Yield –

VitaNova Life Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

VitaNova Life Sciences's gross margin for the twelve months ending Jul 31, 2026 was 26.9%. For fiscal 2026 it was 30.1%, against 59.2% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Apr 30, 202630.1%−29.1
FY2025Apr 30, 202559.2%−7.0
FY2024Apr 30, 202466.2%−33.8
FY2023Apr 30, 2023100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jul 31, 20269.5%−56.7
Q4 FY2026CQ1 2026Apr 30, 202614.8%−44.4
Q3 FY2026CQ4 2025Jan 31, 202644.6%−16.8
Q2 FY2026CQ3 2025Oct 31, 202561.1%+7.7
Q1 FY2026CQ2 2025Jul 31, 202566.2%−1.3
Q4 FY2025CQ1 2025Apr 30, 202559.3%−5.3
Q3 FY2025CQ4 2024Jan 31, 202561.4%−38.6
Q2 FY2025CQ3 2024Oct 31, 202453.3%–
Q1 FY2025CQ2 2024Jul 31, 202467.5%–
Q4 FY2024CQ1 2024Apr 30, 202464.6%–
Q3 FY2024CQ4 2023Jan 31, 2024100.0%–

More VitaNova Life Sciences figures

See a number that looks wrong?